Compare Iovance Biotherapeutics Inc. Common Stock (IOVA) vs IQIYI Inc - ADR (IQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Iovance Biotherapeutics Inc. Common Stock vs IQIYI Inc - ADR — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $14.62 (market cap $6.04B), while IQIYI Inc - ADR trades at $1.02 (market cap $974.67M). The key difference: Iovance Biotherapeutics Inc. Common Stock is far larger — about 6.2× IQIYI Inc - ADR's market cap, and Iovance Biotherapeutics Inc. Common Stock is trading nearer its 52-week high, IQIYI Inc - ADR nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Iovance Biotherapeutics Inc. Common Stock for 0 Days and IQIYI Inc - ADR for 55 Days on average.
| IOVA | IQ | |
|---|---|---|
Market Cap | $6.04B | $974.67M |
Volume | 14,805,993 | 4,964,108 |
Sector | Health | Media |
52-Week High | $14.82 | $2.35 |
52-Week Low | $1.81 | $0.86 |
Typical Hold Time | 0 Days | 55 Days |
Enterprise Value | $5.97B | $2.47B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
iQIYI (IQ) trades at $1.02, up 0.49% with bearish technical signals despite recent earnings beats. The company faces revenue contraction to $27.29B in 2025 and negative net margins (-3.22%), though valuation ratios like P/S (0.25) and P/B (0.52) appear attractive. Recent news highlights AI-driven content initiatives, including the successful 'The Ferry Man' series, as management pivots to offset streaming declines.
Outlook remains challenged by sustained losses and competitive pressures, but analyst consensus leans bullish (50% Buy ratings). Key risks include execution on AI content monetization and Chinese regulatory environment. The stock's deep value profile offers speculative appeal if operational turnaround materializes.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Iovance Biotherapeutics Inc. Common Stock
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →About IQIYI Inc - ADR
iQIYI Inc is an online entertainment service provider in China. It is primarily engaged in providing a variety of services encompassing internet video, live broadcasting, online games, online literature, animations, e-commerce, and social media platform. The company produces original video content and distributes appealing professionally produced content, partner-generated content, and user-generated content. It also offers a diverse collection of internet video content that appeals to users from broad demographics. The company's revenue is generated from membership services and online advertising services. The company earns most of its revenue from China.
Read more on IQ →
